April 18, 2019 + Jessica Di Palo
5 Min read
Basel, April 9th, 2019 MTIP presented its journey in the healthtech sector with its insights on the current industry developments, its great portfolio and an exciting outlook of the future with MTIP Fund ll.
The MTIP Healthcare Clinic 2019 took place in the Victoria Hotel Basel. The guests were welcomed by MTIP’s chairman Dr. Felix Grisard and in the following overview, Dr. Christoph Kausch enlightened the invited audience about MTIP’s main differentiators. MTIP is one of the leading European investors in Healthtech and connects the traditional healthcare sector with new technologies, emerging from the IT sector. By being one of the least digitalized sectors and decreasing productivity over the last couple of years, healthcare strives for improvements. Digitalization in healthcare is just emerging and offers enormous opportunities which are mainly uncorrelated to the traditional financial markets and therefore offer a highly attractive risk-reward profile for investors.
Based on this, Dr. Claudia Colciago presented MTIP’s view on future developments in the healthcare sector and emphasized the importance of investing in companies with a strong and sustainable growth trajectory. Artificial intelligence will have a major impact on healthcare, but AI technology can only be leveraged if a robust framework to collect, structure, and share data is established beforehand. In the future, Digital Health companies will help in delivering affordable and efficient care to patients all around the globe.
Speaking about excellent examples of affordable and efficient care, MTIP’s portfolio was presented by the investment partner David Germonpré. Last year’s new investments Quanta Dialysis, Lumeon and Cynerio were presented by their respective management team. Thanks to their expertise, the audience had a deep dive into several hot topics around chronic diseases, decentralized care, optimization of treatment delivery and cybersecurity.
MTIP was able to establish this great portfolio in under three years and more is coming. The future steps and the key terms of the MTIP Fund II concluded the presentations. The audience was fascinated by MTIP’s development and engaged in insightful discussion during the Apéro riche, enjoying a stunning view over Basel.
Christoph Kausch selected by Real Deals as most influential for 2022
Christoph Kausch named by Real Deals most influential for 2022
MTIP leads €17 million financing round in virtual fertility clinic Apricity
New MTIP investment
MTIP leads the €20 million growth financing round in LynxCare
Largest capital round ever in digital health in Belgium
Pioneering the use of machine learning algorithms to turbo-charge drug development
Intelligencia revolutionizes drug development
The psychology of decision making
What makes a good investor?
Revolutionizing medical triage with artificial intelligence
Mediktor's solution for medical triage
MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments
MTIP Fund II is closed!
Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics
Cynerio's new product Cynerio Now!
MTIP invests in Mediktor
New investment in Mediktor
SFDR Art. 8 or Art. 9? What’s the difference?
SFDR: getting the terminology right
MTIP participates in Oviva’s new $80m Series C funding
Oviva raises $80 million financing round
MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence
MTIP's new investment in Intelligencia
Private Equity 101: Part one – Glossary
Are you new to the healthtech space?
Leading brands revolutionize care journeys with Lumeon
How Lumeon orchestrates care journey
Trialbee – our hero in patient matching and recruiting for clinical trials
Trialbee - patient matching and recruiting
Digital healthcare: patient-first?
Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital
SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?
New SFDR obligations
MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation
First Closing of Fund II
How to pitch to a healthtech Investor
MTIP invests in Koa Health to make mental health treatment more accessible
New investment in Koa Health
MTIP scored fantastic grades in the UNPRI assessment report of 2020
UNPRI Report grades 2020
4 Health VCs Share Their Business Priorities and What is Next
MTIP invests in Trialbee
New investment in Trialbee
TytoCare closes $50 million round as the demand for telehealth accelerates
TytoCare closes new round
The digital healthtech sector is expanding – and so are we!
Two new empolyees start in April